Pharmacokinetics of ketamine and norketamine enantiomers after racemic or S-ketamine IV bolus administration in dogs during sevoflurane anaesthesia

Research in Veterinary Science
Noemi RomagnoliRegula Bettschart-Wolfensberger

Abstract

The aims of this study were to measure plasma levels of R- and S-ketamine and their major metabolites R- and S-norketamine following single intravenous bolus administration of racemic or S-ketamine in sevoflurane anaesthetised dogs and to calculate the relevant pharmacokinetic profiles. Six adult healthy beagle dogs were used in the study. An intravenous bolus of 4mg/kg racemic ketamine (RS-KET) or 2mg/kg S-ketamine (S-KET) was administered, with a three-weeks washout period between treatments. Venous blood samples were collected at fixed times until 900min and R- and S-ketamine as well as R- and S-norketamine plasma levels determined by liquid chromatography coupled with tandem mass spectrometry. Cardiovascular parameters were recorded during the anaesthesia until 240min. All dogs recovered well from anaesthesia. No statistical differences between groups were detected in any cardiovascular parameter. The pharmacokinetics of S-ketamine did not differ when injected intravenously alone or as part of the racemic mixture in dogs anaesthetised with sevoflurane. Following racemic ketamine, the area under the curve of R-norketamine was statistically higher than the one of S-norketamine.

References

Apr 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K YamaokaT Uno
Dec 1, 1992·Anesthesiology·E D Kharasch, R Labroo
Dec 1, 1991·Journal of Veterinary Pharmacology and Therapeutics·J DeleforgeP Delatour
Jun 1, 1991·Journal of Veterinary Pharmacology and Therapeutics·P DelatourD Fau
Apr 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·I M SchwiegerC C Hug
Apr 1, 1980·Journal of Pharmacokinetics and Biopharmaceutics·J S Kaka, W L Hayton
Feb 1, 1997·Journal of Pharmacokinetics and Biopharmaceutics·B TukJ W Mandema
Feb 6, 1998·Der Anaesthesist·H A Adams, C Werner
Nov 24, 2001·Clinical Pharmacology and Therapeutics·H IhmsenJ Schüttler
Oct 15, 2005·Acta Anaesthesiologica Scandinavica·A SchmidtJ Akeson
Jul 22, 2008·Journal of Veterinary Pharmacology and Therapeutics·J C DuqueV E Soares
Nov 5, 2008·Analytical and Bioanalytical Chemistry·M SergiF S Romolo
Nov 27, 2008·Schweizer Archiv für Tierheilkunde·M P LarenzaR Bettschart-Wolfensberger
Feb 6, 2010·Current Opinion in Critical Care·Stephan M Jakob

❮ Previous
Next ❯

Citations

Feb 12, 2021·Electrophoresis·Jitka Caslavska, Wolfgang Thormann
Jun 15, 2021·Drug Testing and Analysis·Andrea BarbarossaGiampiero Pagliuca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.